Author

Devin S. Brandt

Access to Advanced Health Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:host-pathogen & immune response· 2 Research Focus:drug response / drug discovery· 1 Organism:multiple species· 1 Organism:rat· 1

Frequent Co-Authors

Darshan N. KasaliD· 3 shared Emily A. VoigtiD· 3 shared Julie Bakken· 3 shared Alana GerhardtiD· 2 shared Christopher Press· 2 shared Eduard H. MeliefiD· 2 shared Ethan LoiD· 2 shared Jasneet Singh· 2 shared

Activity by Year

2025-2025 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Darshan N. KasalORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The ID93 + GLA-3M-052-LS vaccine candidate elicits mucosal and systemic immunogenicity and protective efficacy against Mycobacterium tuberculosis challenge in BCG-primed Collaborative Cross inbred mice

Emily A. Voigt, Anas Alsharaydeh, Darshan N. Kasal, Madeleine F. Jennewein, Devin S. Brandt, Susan Xiaoqin Lin, Jasneet Singh, Julie Bakken, Raodoh Mohamath, Pauline Fusco, Jordi Bertran Torrelles, Gillian Beamer, Christopher B. Fox

This study evaluates a TB vaccine candidate, ID93 + GLA-3M-052-LS, showing enhanced mucosal and systemic immunity and protection against Mtb in BCG-primed mice.

bioRxiv · Oct 31, 2025 · PreprintImmunology

A Spray Dried Replicon Vaccine Platform for Pandemic Response

Wynton D. McClary, John Z. Chen, Hui Wang, Ethan Lo, Julie Bakken, Joseph McCollum, Christopher Press, Eduard H. Melief, Devin S. Brandt, Andrew R. Martin, Reinhard Vehring, Darshan N. Kasal, Emily A. Voigt, Alana Gerhardt

This paper demonstrates the successful spray drying of a replicon-NLC vaccine against H5N1 avian influenza, maintaining stability and immunogenicity for up to 3 months at 4°C.

International Journal of Pharmaceutics · May 26, 2025Peer-reviewedImmunology

Development of an Intranasally- and Intramuscularly-Administrable Replicon Vaccine Efficacious Against H5N1 Influenza Virus

Wynton D. McClary, Devin S. Brandt, Madeleine F. Jennewein, Jasneet Singh, Samuel Beaver, Matthew Ykema, Christopher Press, Eduard H. Melief, Julie Bakken, Pauline Fusco, Ethan Lo, Peter Battisti, Noah Cross, Darshan N. Kasal, Airn E. Hartwig, , Emily A. Voigt

This paper develops a replicon vaccine against H5N1 influenza that can be administered intranasally or intramuscularly, showing efficacy in reducing morbidity and mortality in a ferret model.

bioRxiv · Mar 31, 2025 · PreprintImmunology